Your browser doesn't support javascript.
loading
Patient-Specific Pharmacokinetics and Dasatinib Nephrotoxicity.
Adegbite, Benjamin O; Abramson, Matthew H; Gutgarts, Victoria; Musteata, Florin M; Chauhan, Kinsuk; Muwonge, Alecia N; Meliambro, Kristin A; Salvatore, Steven P; El Ghaity-Beckley, Sebastian; Kremyanskaya, Marina; Marcellino, Bridget; Mascarenhas, John O; Campbell, Kirk N; Chan, Lili; Coca, Steven G; Berman, Ellin M; Jaimes, Edgar A; Azeloglu, Evren U.
Affiliation
  • Adegbite BO; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Abramson MH; Internal Medicine, Mount Sinai Morningside/West, New York, New York.
  • Gutgarts V; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Musteata FM; Renal Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chauhan K; Department of Pharmaceutical Sciences, Albany College of Pharmacy & Health Sciences, Albany, New York.
  • Muwonge AN; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Meliambro KA; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Salvatore SP; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • El Ghaity-Beckley S; Clinical Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York.
  • Kremyanskaya M; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Marcellino B; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Mascarenhas JO; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Campbell KN; Division of Hematology/Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Chan L; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Coca SG; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Berman EM; Division of Nephrology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
  • Jaimes EA; Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Azeloglu EU; Renal Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Clin J Am Soc Nephrol ; 18(9): 1175-1185, 2023 09 01.
Article in En | MEDLINE | ID: mdl-37382967
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Type of study: Risk_factors_studies Limits: Humans Language: En Journal: Clin J Am Soc Nephrol Journal subject: NEFROLOGIA Year: 2023 Document type: Article